Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis
Anselm Jorda, Manuel Kussmann, Nebu Kolenchery, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults
Kun Xu, Zihan Wang, Maorong Qin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 30
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Jiaying Shen, Junyan Fan, Yue Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life (2022) Vol. 12, Iss. 11, pp. 1758-1758
Open Access | Times Cited: 22
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study
Sammy Huygens, Tim Preijers, Francis Swaneveld, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 4, pp. 497-509
Open Access | Times Cited: 3
Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity
Raymund R. Razonable
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentation
Hyung Park, Chang Yu, Liise‐anne Pirofski, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients
Yan Leyfman, Nancy Emmanuel, Gayathri P. Menon, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Beneficial and Harmful Effects of Monoclonal Antibodies for the Treatment and Prophylaxis of COVID-19: Systematic Review and Meta-Analysis
Adrían V. Hernández, Alejandro Piscoya, Vinay Pasupuleti, et al.
The American Journal of Medicine (2022) Vol. 135, Iss. 11, pp. 1349-1361.e18
Open Access | Times Cited: 15
Charting a path forward: Promising outcomes of convalescent plasma therapy in the care of severely B‐cell depleted patients with persistent COVID‐19
Tsofia Inbar, Eldad J. Dann, Omer Kerner, et al.
Transfusion (2024) Vol. 64, Iss. 3, pp. 443-448
Closed Access | Times Cited: 2
A review and analysis of outcomes in randomized clinical trials of plasma transfusion in patients with bleeding or for the prevention of bleeding: The BEST collaborative study
Torunn Oveland Apelseth, Sheharyar Raza, Jeannie Callum, et al.
Transfusion (2024) Vol. 64, Iss. 6, pp. 1116-1131
Open Access | Times Cited: 2
Interface‐Guided Computational Protein Design Reveals Bebtelovimab‐Resistance Mutations in SARS‐CoV‐2 RBD: Correlation with Global Viral Genomes and Bebtelovimab‐Escape Mutations
Shweata Maurya, S Rajesh Kumar, Aditya K. Padhi
ChemistrySelect (2023) Vol. 8, Iss. 46
Closed Access | Times Cited: 6
The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials
Zhenbei Qian, Zhijin Zhang, Haomiao Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Clinical–Epidemiological Profile of COVID-19 Patients Admitted during Three Waves of the Pandemic in a Tertiary Care Center, in Belém, Pará, Amazon Region of Brazil
Ana Beatriz Nunes Pereira, Fernando Sérgio Henriques Pereira, Júlio Araujo, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1233-1233
Open Access | Times Cited: 1
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Reinforcement of the Standard Therapy with Two Infusions of Convalescent Plasma for Patients with COVID-19: A Randomized Clinical Trial
Joan Bargay-Lleonart, Fiorella Sarubbo, María J Arrizabalaga, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3039-3039
Open Access | Times Cited: 6
Defining Parameters That Modulate Susceptibility and Protection to Respiratory Murine Coronavirus MHV1 Infection
Elvia E. Silva, Steven J. Moioffer, Mariah Hassert, et al.
The Journal of Immunology (2023) Vol. 212, Iss. 4, pp. 563-575
Closed Access | Times Cited: 3
COVID 19: Prevention and treatment through the Indian perspective
Harish Chandra, Archana Yadav, Rajendra Prasad, et al.
Cytokine (2024) Vol. 183, pp. 156756-156756
Closed Access
Retinal and Corneal OCT Results of Patients Hospitalized and Treated in the Acute Phase of COVID-19
Edward Wylęgała, Aleksandra Prus-Ludwig, Patrycja Mocek, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5564-5564
Open Access
Effects of Vitamin C Supplements on Clinical Outcomes and Hospitalization Duration for Patients with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
Maorong Qin, Kun Xu, Zhuo Chen, et al.
Nutrition Reviews (2024)
Closed Access
Assessment of the impact of pathogen reduction technologies on the neutralizing activity of COVID-19 convalescent plasma.
Salwa Hindawi, Tarek Elgemmezi, Sherif A. El‐Kafrawy, et al.
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 3, pp. 103688-103688
Open Access | Times Cited: 1
Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulins: a phase I/II dose finding study
Sammy Huygens, Tim Preijers, Francis Swaneveld, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
Tetsuya Suzuki, Yusuke Asai, Kozue Takahashi, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20568-e20568
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top